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Voltage-Dependent Modulation of Cardiac Ryanodine Receptors (RyR2)
by Protamine
Paula L. Diaz-Sylvester, Julio A. Copello.
Dept. of Pharmacology, Southern Illinois University, School of Medicine,
Springfield, IL, USA.
Early studies showed that protamine (>20mg/ml) inhibits skeletal RyR1 regard-
less of the cytosolic Ca2þ levels (Koulen et al., Mol. Biol. Cell. 11:2213–9,
2000).We extended these studies to cardiac RyR2 reconstituted into planar lipid
bilayers. We found that protamine (0.2mg/ml) added to the cytosolic surface of
RyR2 decreased channel activity. This effect did not depend on cytosolic
Ca2þ levels or on the presence/absence of agonists. The action of protamine
was complex and involved transition to several substates as well as full block
of the channel. Substates did not seem to represent protaminebinding to a ryanoid
site as they were observed in ryanodine-modified channels. At Vm> 0mV (SR
lumen - cytosol) block events were rare and only the substate with the highest
level of conductance had high probability. As expected, increasing Vm from
0 to þ80mV, decreased the apparent on-rate of protamine-induced substate
and increased its off-rate. Unexpectedly, the I-V relationships for the full open-
ings and for the protamine-induced substate were parallel (i.e., the current am-
plitude drop induced by protamine had the same magnitude at 0 and þ80mV).
This is not the case with most known conductance modifiers, which induce
a drop in the current amplitude that changes proportionally with the amplitude
of the full opening. In contrast, the modifications in the RyR2 conduction path-
way induced by protamine (conformational changes or partial occlusion of the
pore) heavily depended on the electric field. Analogous electrostatic interactions
between neighboringRyRs and/orwith associated proteinsmay play a role in the
heterogeneity of RyRs current amplitudes frequently observed in multichannel
recordings (Supported by NIH R01 GM078665 to JAC).
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SAM Regulation of RyR2
Angela J. Kampfer, Edward M. Balog.
Georgia Institute of Technology, Atlanta, GA, USA.
RyR2 channel activity is subject to allosteric and posttranslational regulation.
S-adenosyl-L-methionine (SAM), the primary methyl group donor for en-
zyme-mediated methylation of proteins and other biological targets, activates
RyR2 via an unknown mechanism. To determine if activation of RyR2 by
SAM requires methyltransferase activity, cardiac sarcoplasmic reticulum
(CSR) vesicle [3H]ryanodine binding was performed in media containing
150 mM KCl, 20 mM PIPES pH 7.0, 3 mM Ca2þ, 1 mM SAM, and 0–1 mM
sinefungin, a competitive methyltransferase inhibitor. Sinefungin did not alter
CSR vesicle [3H]ryanodine binding, and the SAM-induced increase in [3H]rya-
nodine binding was not altered by sinefungin. To investigate further whether
activation of RyR2 by SAM involves RyR2 methylation, RyR2 was immuno-
precipitated from CSR vesicles pretreated for 30 min at 37C with 3 mCi; 285
nM [3H]SAM plus or minus 500 fold excess cold SAM or 1 mM SAH, an in-
hibitor of methyltransferase activity, followed by centrifugation through su-
crose. Radioactivity incorporated into pretreated CSR and immunoprecipitated
RyR2 was determined by liquid scintillation counting. Although the amount of
radioactivity incorporated into [3H]SAM pretreated CSR vesicles was reduced
from 6.54 to 1.86 and 1.69 pmol [3H]SAM/mg protein in the presence of SAH
and excess cold SAM respectively, the amount of radioactivity recovered by
immunoprecipitation with anti-RyR was not increased over control (immuno-
precipitation without RyR specific antibody). Because SAM contains an aden-
osine moiety and may activate RyR2 via interaction with the channel’s adenine
nucleotide binding site(s), the affects of SAM and ATP on RyR2 activity were
compared. The SAM and ATP concentration dependence of CSR vesicle
[3H]ryanodine binding virtually overlapped with no differences at any concen-
tration tested. This work suggests SAM does not methylate RyR2 and the sim-
ilarities between ATP- and SAM-induced RyR2 activation support allosteric
regulation of RyR2 by SAM.
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Targeted Stabilisation Of The RyR2 I-Domain Restores Ca2þ Handling
And Intercellular Synchrony In Ouabain-disrupted Cardiac Cell Mono-
layers
Hala Jundi, F. Anthony Lai, Christopher H. George.
Wales Heart Research Institute, Cardiff University, Cardiff, United Kingdom.
Stabilisation of cardiac ryanodine receptors (RyR2) has emerged as an impor-
tant approach for normalising Ca2þ cycling dysfunction in cardiac disease.
Here, we targeted the I-domain of human RyR2, a region critically involved
in RyR2 intramolecular rearrangement following channel activation. The I-do-
main is a hot-spot for arrhythmia-linked mutations that destabilise the activated
channel. Putative functional motifs within the I-domain were mapped usinga bioinformatics approach and the synthesised using an in vitro expression sys-
tem. The efficacy of affinity-purified fragments in normalising Ca2þ handling
and intercellular coupling was screened using a cardiac-cell model of oua-
bain-induced dysynchrony. Under defined experimental conditions, ouabain
perturbs normal intracellular Ca2þ cycling and ablates the synchronous inter-
cellular coupling in super-confluent HL-1 monolayers. A 146 amino acid frag-
ment, termed IDB, normalised ouabain-induced Ca2þ dysfunction and resulted
in the re-synchronisation of Ca2þ transients across the monolayer. In the same
ouabain-disrupted model , bacterially-synthesised IDB increased the extent of
intercellular synchrony to levels greater than those measured in naı¨ve (non-oua-
bain treated) spontaneously contractile HL-1 cells. The fortuitous presence of
overlapping, truncated recombinant fragments that spanned the entire IDB
sequence and co-purified with intact IDB from bacterial culture may have con-
tributed to these effects. Importantly, IDB-mediated normalisation of Ca2þ han-
dling and intercellular synchronisation within the ouabain-treated monolayer
extended to distant cell populations that had not been transduced with the
recombinant protein. In experiments using cyan-yellow bio-engineered RyR2
(CYBER) probes that report intra-RyR2 conformational rearrangement, we
showed that the IDB-mediated stabilisation of the RyR2 channel directly corre-
lated with the normalisation of ouabain-induced Ca2þ dysfunction. Our data
provides evidence that a specific epitope-targeting strategy can stabilise RyR2
and that this approach may have remarkable therapeutic utility in normalising
channel abnormalities associated with acquired and genetic cardiac disease.
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The Effect of Volatile Anaesthetics on the Cardiac Ryanodine Receptor
Derek R. Laver, Tony Quail, Holly Sitsapesan, Dirk F. VanHelden.
University of Newcastle, Callaghan, Australia.
Although volatile anaesthetics serve a crucial role in preventing pain they con-
tinue to have side effects such as their ability to excite Ca2þ release from the
sarcoplasmic reticulum (SR) via the ryanodine receptor calcium release chan-
nels (RyR). Here we report the first detailed investigation on the effects of vol-
atile anaesthetics on the function of cardiac RyRs.
RyRs were isolated from sheep hearts and incorporated into artificial lipid bi-
layers and subjected to single channel recording. Clinical doses of halothane
and isoflurane increased RyR activation by luminal and cytoplasmic Ca2þ by
increasing channel open time and opening frequency. The Ka’s for halothane
and isoflurane were 1 mM and 3 mM, respectively. However, the maximal ef-
fect of halothane (5-fold increase in placePo) was ~3-fold larger than that for
isoflurane. These agents activated RyRs by interacting with cytoplasmic do-
mains distinct from the ATP activating sites.
The effects of halothane on RyR regulation by luminal and cytoplasmic Ca2þ
and Mg2þ were accurately fitted by a luminal-triggered calcium feedthrough
model involving four Ca2þ sensing mechanisms on each RyR subunit; two ac-
tivation sites (luminal L-site, 40 mM affinity; cytoplasmic A-site, 1 mM affinity)
and two cytoplasmic inactivation sites (I1-site, 10 mM affinity; I2-site, 1 mM
affinity). Halothane did not appear to alter the ion binding affinities for these
sites. Rather, it increased channel opening rate and decreased the channel clos-
ing rate associated with Ca2þ binding to the two activation sites.
The potentiating effect of halothane on luminal Ca2þ activation of cardiac
RyRs was due to 1) an increase on opening frequency because of synergistic
actions of the luminal and cytoplasmic (L and A) sites and 2) an increase in
open time because of Ca2þ feedthrough to the A-site.
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Iron (II) Modulation of the Cardiac Ryanodine Receptor (RyR2)
Daniel T. Baptista-Hon1, Austin C. Elliott2, Mary E. Diaz1.
1University of Edinburgh, Edinburgh, United Kingdom, 2University of
Manchester, Manchester, United Kingdom.
Cardiomyopathies and arrhythmias are major causes of mortality in chronic iron
overload. There is evidence that iron overload impairs cardiomyocytes Ca2þ ho-
meostasis (Baptista-Hon et al, 2005). However its molecular substrates remain
unknown. Cardiac ryanodine receptors (RyR2) dysfunction is implicated in sev-
eral diseases where Ca2þ homeostasis is lost.We therefore wanted to investigate
RyR2 role as a potential target for iron-induced cardiomyopathies.
We isolated heavy sarcoplasmic reticulum (HSR) vesicles containing RyR2
from sheep hearts. RyR2 were reconstituted into L-a-phosphatidylethanol-
amine (PE) bilayers. Unitary currents were measured under voltage-clamp
with 250mMCsþ as the charge carrier and 10mM activating Ca2þ. High affinity
[3H]ryanodine binding of the native vesicles was detected by liquid scintillation
counting. Non-specific binding determined by incubations with 100x cold
ryanodine.
Fe2þ reduced RyR2 open probability and conductance in a dose dependentman-
ner. Lifetime analysis revealed 5 shut times components and 3 open times com-
ponents in control. Fe2þ caused an extra-shut component. Furthermore, there
